Dynavax Receives Notification of PDUFA Extension for HEPLISAV-B to December 15, 2016
BERKELEY, CA--(Marketwired - April 27, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) will require additional time to complete its review of the Biologics License Application (BLA) …